An aging population, an increase in Americans that are covered by health insurance thanks to Obamacare and a wide-reaching effort to curtail and control the cost of care, while making Americans healthier and preventing disease – all of these trends are converging to make healthcare technology, life sciences and biotechnology hot industries.
One of the local companies that is benefiting from this increase in interest and investment in life sciences is Ceres Nanosciences Inc., a privately held life sciences company engaged in the research, development, and commercialization of innovative sample preparation products and diagnostic tests, based on its proprietary Nanotrap technology.
Ceres was founded in 2009 as a spin out company of George Mason University in Northern Virginia. Their solutions help to detect diseases and health issues earlier, enabling them to be treated more quickly and more effectively.
Ceres was one of many exciting companies that took part in one of the two Technology Showcases at this year’s Mid-Atlantic Growth Conference, which was sponsored by the National Capital Chapter of ACG. During these showcases, executives from some of the most exciting, innovative and disruptive technology enterprises in the region presented their companies and instructed the ACG membership – and others in attendance – about the trends and market factors that are driving demand for their solutions.
During his presentation, the CEO of Ceres, Ross Dunlap, discussed the company’s offerings, what differentiates them from other testing solutions and why some very interesting organizations – including the United States military – are interested in the company’s proprietary technologies.
Here is what Ross had to say:
Corporate Growth, Capital Style will be back with more videos in the TechSource series in the coming weeks. For more information about Ceres Nanosciences, click HERE to go to their corporate Website, or click HERE to read an exclusive interview with their CEO, Ross Dunlap.